Brief: Everest Organics Gets Korea Drug Master File Approval For Its Rabeprazole Sodium API
18/02/2025 10:37
Feb 18 (Reuters) - Everest Organics Ltd EVER.BO :
* GETS KOREA DRUG MASTER FILE APPROVAL FOR ITS RABEPRAZOLE
SODIUM
API
Source text: ID:nBSE6fkNMq
Further company coverage: EVER.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Everest Organics
See all newsBrief: Everest Organics Gets Korea Drug Master File Approval For Its Rabeprazole Sodium API
Brief: Everest Organics To Consider Fund Raising
Brief: Everest Organics Names Srikakarlapudi Sirisha As MD
Brief: Everest Organics Gets Permanent Revocation Of Factory Closure Order
India's Everest Organics starts making ingredient for Merck's COVID-19 pill (updated)